Method of treating atherosclerosis, dyslipidemias and related conditions

Details for Australian Patent Application No. 2006214018 (hide)

Owner Merck & Co., Inc. Merck Sharp & Dohme Limited

Inventors Hardy, Ian; Lai, Eseng; Fitzpatrick, Shaun; Waters, M. Gerard; Seiler, Christian

Agent A J Park

Pub. Number AU-A-2006214018

PCT Pub. Number WO2006/089309

Priority 60/654,703 17.02.05 US

Filing date 15 February 2006

Wipo publication date 24 August 2006

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089309 Priority application(s): WO2006/089309

13 May 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Merck Sharp & Dohme Limited

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214021-Orally bioavailable CCI-779 tablet formulations

2006214016-Autonomous surface cleaning robot for wet and dry cleaning